UNSPSC 51281703: Ampicillin

This classification denotes a penicillin antibiotic with the molecular formula C16H19N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C782967RD, chemically known as penicillin, (aminophenylmethyl)- but generally known as ampicillin, which bears US NIH Compound Identifier 2174.

UNSPSC 51281703 Ampicillin, a Commodity code, shows minimal direct activity in recent state and local procurement; the posted opportunities tagged to this code involve naloxone, first-aid supplies, and multi-source pharmaceuticals that fall outside the scope of a single-molecule antibiotic. State and local buyers do procure pharmaceuticals — as demonstrated by the Texas Health and Human Services Commission's direct-to-manufacturer prescription initiative and the Minnesota Multistate Cooperative Purchasing Alliance's generic multi-source pharmaceutical contracts — but ampicillin specifically does not appear in the representative recent solicitations. When pharmaceuticals are solicited at the commodity level, procurement is typically bundled into broader categories (generic multi-source drugs, OTC products, or emergency medical supplies) rather than individual agents, and contracting often flows through cooperative purchasing vehicles or authorized wholesaler networks rather than direct manufacturer procurement.

The geographic spread of pharmaceutical procurement activity spans Texas, Minnesota, and Florida, with participation from state health agencies, cooperative purchasing alliances, county health departments, and municipal fire-rescue divisions. The Minnesota Multistate Cooperative Purchasing Alliance RFP (due March 26, 2026) established multiple contracts for generic pharmaceuticals across state and local members including Oregon; Seminole County, Florida's naloxone procurement (IFB 60459723LAS, due July 26, 2023) sought 1,900 units annually for community health initiatives; and the City of Tampa's first-aid supplies bid (26P00145) supported the Fire Department Rescue Division. The Texas HHS RFI (posted April 3, 2026) explored direct-to-manufacturer prescription models outside traditional pharmacy benefit manager and group purchasing organization channels. Ampicillin procurement at the commodity level does not appear in these representative opportunities, suggesting that pursuit under this code requires engagement with bulk pharmaceutical contracts, cooperative agreements, or health system formulary management rather than direct commodity solicitations.